Investor Presentaiton

Sustained Profitability Vs. Peers Superior business model Margins consistently higher than peers# Gross Margin EBITDA Margin 75% 73% 83% 82% 80% 75% 63% 61% 62% 62% 59% 60% 34% 34% Net Margin 44% 45% 35% 34% 33% 32% 32% 41% SUN PHARMA 18% 29% 14% 14% 12% 13% 9% 7% 22% 20% 20% 19% 19% 17% FY10 FY11 FY12 FY13 FY14 FY15* FY10 FY11 FY12 FY13 FY14 FY15* FY10 FY11 FY12 FY13 FY14 FY15* Sun Pharma Range of Top 10 Indian Pharma Cos. Average Gross margin= (Net Sales - Material Cost) / Net Sales * 100 #Top 10 Indian Pharma company include Aurobindo, Cadila Healthcare, Cipla, DRL, Glenmark, Ipca, Lupin, Ranbaxy, Torrent and Wockhardt. Sun Pharmaceutical Industries Limited. All Rights Reserved. FY15 numbers include the impact of Ranbaxy merger 12

View entire presentation